CoChat

Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity

Open access

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Hepatic gene transfer, in particular using adeno-associated viral (AAV) vectors, has been shown to induce immune tolerance to several protein antigens. This approach has been exploited in animal models of inherited protein deficiency for systemic delivery of therapeutic proteins. Adequate levels of transgene expression in hepatocytes induce a suppressive T cell response, thereby promoting immune tolerance. This study addresses the question of whether AAV gene transfer can induce tolerance to a cytoplasmic protein. MAJOR FINDINGS: AAV-2 vector-mediated hepatic gene transfer for expression of cytoplasmic beta-galactosidase (beta-gal) was performed in immune competent mice, followed by a secondary beta-gal gene transfer with E1/E3-deleted adenoviral Ad-LacZ vector to provoke a severe immunotoxic response. Transgene expression from the AAV-2 vector in approximately 2% of hepatocytes almost completely protected from inflammatory T cell responses against beta-gal, eliminated antibody formation, and significantly reduced adenovirus-induced hepatotoxicity. Consequently, approximately 10% of hepatocytes continued to express beta-gal 45 days after secondary Ad-LacZ gene transfer, a time point when control mice had lost all Ad-LacZ derived expression. Suppression of inflammatory T cell infiltration in the liver and liver damage was linked to specific transgene expression and was not seen for secondary gene transfer with Ad-GFP. A combination of adoptive transfer studies and flow cytometric analyses demonstrated induction of Treg that actively suppressed CD8(+) T cell responses to beta-gal and that was amplified in liver and spleen upon secondary Ad-LacZ gene transfer. CONCLUSIONS: These data demonstrate that tolerance induction by hepatic AAV gene transfer does not require systemic delivery of the transgene product and that expression of a cytoplasmic neo-antigen in few hepatocytes can induce Treg and provide long-term suppression of inflammatory responses and immunotoxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0006376

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow chart of experimental design. First, AAV2-LacZ hepatic gene transfer was performed. A secondary I.V. delivery of Ad-LacZ (or Ad-GFP) was performed 6 weeks later or in naïve mice to provoke an immunotoxic response. Samples were taken and experiments were performed 10 and 45 days after Ad delivery. Splenic CD4+CD25+ T cells were adoptively transferred to naïve mice 6 weeks after AAV2-LacZ gene transfer or 10 days after secondary Ad-LacZ delivery. Recipient mice were immunized with a peptide encoding the dominant CD8+ T cell epitope for β-gal in this strain. All animals were C57BL/6 mice.
Figure 1 Flow chart of experimental design. First, AAV2-LacZ hepatic gene transfer was performed. A secondary I.V. delivery of Ad-LacZ (or Ad-GFP) was performed 6 weeks later or in naïve mice to provoke an immunotoxic response. Samples were taken and experiments were performed 10 and 45 days after Ad delivery. Splenic CD4+CD25+ T cells were adoptively transferred to naïve mice 6 weeks after AAV2-LacZ gene transfer or 10 days after secondary Ad-LacZ delivery. Recipient mice were immunized with a peptide encoding the dominant CD8+ T cell epitope for β-gal in this strain. All animals were C57BL/6 mice.CC BY · PubMed Central
Figure 2 Expression of β-gal in viral vector transduced livers. Sections from C57BL/6 mice (3 per animal; separated by 24 microns) were stained for β-gal enzyme activity and counterstained with hemotoxylin nuclear stain. A. Representative images of livers from AAV-LacZ transduced mice (6 weeks or 12 weeks after gene transfer); AAV-LacZ/Ad-LacZ transduced mice (10 days or 45 days after Ad-LacZ administration, which occurred 6 weeks after the initial AAV-LacZ gene transfer); and Ad-LacZ only transduced mice (10 and 45 days after gene transfer). Arrows point toward examples of β-gal+ hepatocytes in AAV-LacZ only transduced livers. Original magnification: 100x. B-C. Percentages of β-gal expressing hepatocytes at day10 (B) or day 45 (C) after Ad-LacZ gene transfer. Data are average±SD for n = 4 mice/experimental group.
Figure 2 Expression of β-gal in viral vector transduced livers. Sections from C57BL/6 mice (3 per animal; separated by 24 microns) were stained for β-gal enzyme activity and counterstained with hemotoxylin nuclear stain. A. Representative images of livers from AAV-LacZ transduced mice (6 weeks or 12 weeks after gene transfer); AAV-LacZ/Ad-LacZ transduced mice (10 days or 45 days after Ad-LacZ administration, which occurred 6 weeks after the initial AAV-LacZ gene transfer); and Ad-LacZ only transduced mice (10 and 45 days after gene transfer). Arrows point toward examples of β-gal+ hepatocytes in AAV-LacZ only transduced livers. Original magnification: 100x. B-C. Percentages of β-gal expressing hepatocytes at day10 (B) or day 45 (C) after Ad-LacZ gene transfer. Data are average±SD for n = 4 mice/experimental group.CC BY · PubMed Central
Figure 3 Liver inflammation. Liver sections were stained with H&E to determine levels of inflammation in the parenchyma and portal ducts at 10 days after and Ad-LacZ or Ad-GFP gene delivery to naïve mice or mice that had received AAV-LacZ gene transfer 6 weeks earlier. AAV-LacZ only transduced mice are shown for comparison (n = 4 per experimental group). A-H. Representative images at original magnification of 50x and 100x illustrate degrees of inflammation from AAV-LacZ, AAV-LacZ/Ad-LacZ, AAV-LacZ/Ad-GFP and Ad-LacZ only groups. A trained pathologist scored the liver inflammation in parenchyma (I) and portal ducts (J) in a blinded fashion to accurately determine the level of inflammation in the groups. Bars represent scores for livers of individual animals.
Figure 3 Liver inflammation. Liver sections were stained with H&E to determine levels of inflammation in the parenchyma and portal ducts at 10 days after and Ad-LacZ or Ad-GFP gene delivery to naïve mice or mice that had received AAV-LacZ gene transfer 6 weeks earlier. AAV-LacZ only transduced mice are shown for comparison (n = 4 per experimental group). A-H. Representative images at original magnification of 50x and 100x illustrate degrees of inflammation from AAV-LacZ, AAV-LacZ/Ad-LacZ, AAV-LacZ/Ad-GFP and Ad-LacZ only groups. A trained pathologist scored the liver inflammation in parenchyma (I) and portal ducts (J) in a blinded fashion to accurately determine the level of inflammation in the groups. Bars represent scores for livers of individual animals.CC BY · PubMed Central
Figure 4 Systemic levels of liver enzymes as indicators of liver damage. Systemic levels of AST (aspartate aminotransferase) and ALT (alanine aminotransferase) liver enzyme levels were measured from plasma for all experimental groups of C57BL/6 mice 10 days after Ad-LacZ or Ad-GFP delivery (i.e. during the acute inflammatory response in the liver) and compared to data from AAV-LacZ transduced mice that did not receive Ad vectors. Data are average±SD for n = 4 mice/experimental group.
Figure 4 Systemic levels of liver enzymes as indicators of liver damage. Systemic levels of AST (aspartate aminotransferase) and ALT (alanine aminotransferase) liver enzyme levels were measured from plasma for all experimental groups of C57BL/6 mice 10 days after Ad-LacZ or Ad-GFP delivery (i.e. during the acute inflammatory response in the liver) and compared to data from AAV-LacZ transduced mice that did not receive Ad vectors. Data are average±SD for n = 4 mice/experimental group.CC BY · PubMed Central
Figure 5 CD8+ cellular infiltrates in adenoviral transduced livers. Liver sections from naïve or AAV-LacZ pre-treated C57BL/6 mice 10 days after Ad-LacZ or Ad-GFP gene transfer. CD8+ cells were stained red with AlexaFluor® 568 while β-gal+ cells were stained green with AlexaFluor® 488. GFP+ cells were green by native fluorescence. A blue-pseudo color after image capture was used to show β-gal+ cells from A. AAV-LacZ/Ad-LacZ and B. Ad-LacZ livers, and the native green fluorescence was used to show GFP+ cells from C. AAV-LacZ/Ad-GFP and D. Ad-GFP livers. E. The ratio of CD8+ staining surrounding either β-gal or GFP producing hepatocytes was determined by capturing the images at 200X and analyzing with Image Pro software. Data are average±SD for n = 4 mice/experimental group. Arrows in A. point toward CD8+ cells.
Figure 5 CD8+ cellular infiltrates in adenoviral transduced livers. Liver sections from naïve or AAV-LacZ pre-treated C57BL/6 mice 10 days after Ad-LacZ or Ad-GFP gene transfer. CD8+ cells were stained red with AlexaFluor® 568 while β-gal+ cells were stained green with AlexaFluor® 488. GFP+ cells were green by native fluorescence. A blue-pseudo color after image capture was used to show β-gal+ cells from A. AAV-LacZ/Ad-LacZ and B. Ad-LacZ livers, and the native green fluorescence was used to show GFP+ cells from C. AAV-LacZ/Ad-GFP and D. Ad-GFP livers. E. The ratio of CD8+ staining surrounding either β-gal or GFP producing hepatocytes was determined by capturing the images at 200X and analyzing with Image Pro software. Data are average±SD for n = 4 mice/experimental group. Arrows in A. point toward CD8+ cells.CC BY · PubMed Central
Figure 6 Antibody formation against β-gal. Graphed are β-gal-specific IgG1 titers as a function of time after Ad-lacZ gene transfer in AAV-LacZ/Ad-LacZ and Ad-LacZ only transduced mice and, for comparison, in AAV-LacZ only mice. Data are average±SD for n = 4 mice/experimental group.
Figure 6 Antibody formation against β-gal. Graphed are β-gal-specific IgG1 titers as a function of time after Ad-lacZ gene transfer in AAV-LacZ/Ad-LacZ and Ad-LacZ only transduced mice and, for comparison, in AAV-LacZ only mice. Data are average±SD for n = 4 mice/experimental group.CC BY · PubMed Central
Figure 7 ELISpot for frequency of IFN-γ secreting lymphocytes following Ad-LacZ gene transfer. A. Frequencies in response to stimulation with mock media, β-gal protein, β-gal CD8+ T cell epitope, or adenoviral particles. Mice had received AAV-LacZ only (6 weeks earlier) or AAV-LacZ followed by Ad-LacZ, or Ad-LacZ only, and assayed 14 days after Ad-LacZ administration. B. Positive control stimulation using 10 µg/ml of Staphylococcal Enterotoxin B (SEB) super antigen. C. Frequencies in recipient mice of adoptively transferred CD4+CD25+ splenocytes from AAV-LacZ, AAV-LacZ/Ad-LacZ, or Ad-LacZ transduced mice. Adoptive transfer was performed 10 days after Ad-LacZ gene transfer (i.e. 6 weeks plus 10 days after AAV-LacZ gene transfer) to C57BL/6 mice. Recipient C57BL/6 mice were immunized the following day with the β-gal CD8+ T cell epitope and assayed 10 days later. Animals receiving cells from naïve mice were included as an additional control group. D. Positive control stimulation using 10 µg/ml of Staphylococcal Enterotoxin B (SEB) super antigen. A-D. In vitro stimulations were performed in triplicate for individual animals. Results are average±SD for n = 4 mice/experimental group.
Figure 7 ELISpot for frequency of IFN-γ secreting lymphocytes following Ad-LacZ gene transfer. A. Frequencies in response to stimulation with mock media, β-gal protein, β-gal CD8+ T cell epitope, or adenoviral particles. Mice had received AAV-LacZ only (6 weeks earlier) or AAV-LacZ followed by Ad-LacZ, or Ad-LacZ only, and assayed 14 days after Ad-LacZ administration. B. Positive control stimulation using 10 µg/ml of Staphylococcal Enterotoxin B (SEB) super antigen. C. Frequencies in recipient mice of adoptively transferred CD4+CD25+ splenocytes from AAV-LacZ, AAV-LacZ/Ad-LacZ, or Ad-LacZ transduced mice. Adoptive transfer was performed 10 days after Ad-LacZ gene transfer (i.e. 6 weeks plus 10 days after AAV-LacZ gene transfer) to C57BL/6 mice. Recipient C57BL/6 mice were immunized the following day with the β-gal CD8+ T cell epitope and assayed 10 days later. Animals receiving cells from naïve mice were included as an additional control group. D. Positive control stimulation using 10 µg/ml of Staphylococcal Enterotoxin B (SEB) super antigen. A-D. In vitro stimulations were performed in triplicate for individual animals. Results are average±SD for n = 4 mice/experimental group.CC BY · PubMed Central
Figure 8 Frequencies of CD4+CD25+Foxp3+ Treg by flow cytometry. A. Example of analysis of splenocytes from a C57BL/6 mouse transduced with AAV-LacZ and, 6 weeks later, with Ad-LacZ. B. Frequencies of CD4+CD25+Foxp3+ splenocytes in AAV-LacZ, AAV2-LacZ/Ad-LacZ, AAV2-LacZ/Ad-GFP, Ad-LacZ, or Ad-GFP transduced C57BL/6 mice. C. Frequencies of CD25+GFP+ intrahepatic lymphocytes (IHL) isolated from FoxP3 reporter mice (knock in mice for FoxP3-IRES-EGFP) after transduction with AAV-LacZ, AAV-LacZ/Ad-LacZ, or Ad-LacZ. A-C. All analyses were done 10 days after Ad gene transfer. Results are average±SD for n = 4 mice/experimental group.
Figure 8 Frequencies of CD4+CD25+Foxp3+ Treg by flow cytometry. A. Example of analysis of splenocytes from a C57BL/6 mouse transduced with AAV-LacZ and, 6 weeks later, with Ad-LacZ. B. Frequencies of CD4+CD25+Foxp3+ splenocytes in AAV-LacZ, AAV2-LacZ/Ad-LacZ, AAV2-LacZ/Ad-GFP, Ad-LacZ, or Ad-GFP transduced C57BL/6 mice. C. Frequencies of CD25+GFP+ intrahepatic lymphocytes (IHL) isolated from FoxP3 reporter mice (knock in mice for FoxP3-IRES-EGFP) after transduction with AAV-LacZ, AAV-LacZ/Ad-LacZ, or Ad-LacZ. A-C. All analyses were done 10 days after Ad gene transfer. Results are average±SD for n = 4 mice/experimental group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 54

Metadata

Authors
Martino, A. T., Nayak, S., Hoffman, B. E., Cooper, M., Liao, G., Markusic, D. M., Byrne, B. J., Terhorst, C., & Herzog, R. W.
Affiliations
  • University of Florida Health (US)
  • University of Florida (US)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Herzog, Roland W.
Venue
PLoS ONE
Published
2009-08-04
Volume
4
Issue
8
Pages
e6376
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2120423141
Cited by
54
References
48
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 6 · 2016: 4 · 2015: 1 · 2014: 8 · 2013: 6 · 2012: 2
FWCI
2.71
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Heart Association
  • University of Florida
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (P01HL078810)
  • National Institute of Allergy and Infectious Diseases (R01AI051390, AI/HL51390)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK074367)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
immune tolerance induction, adeno-associated virus vectors, hepatic gene transfer, antigen presentation, immunotoxicity, regulatory T cells, CD8+ T cell suppression, adoptive transfer, liver inflammation
MeSH terms
Dependovirus, Animals, beta-Galactosidase, Cytoplasm, Genetic Vectors, Immune Tolerance, Liver, Mice, Inbred BALB C, Mice, Inbred C57BL, Transduction, Genetic, Gene Transfer Techniques, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity. https://app.cochat.ai/papers/10.1371/journal.pone.0006376
The paper
Martino, A. T., Nayak, S., Hoffman, B. E., Cooper, M., Liao, G., Markusic, D. M., Byrne, B. J., Terhorst, C., & Herzog, R. W. (2009). Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity. PLoS ONE. https://doi.org/10.1371/journal.pone.0006376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.